Element has responded to the lawsuit with a statement saying, “Element is proud of its strong history of innovation. We are ...

Illumina, Inc. ILMN recently unveiled the DRAGEN version 4.4 software (v4.4), the industry's most comprehensive secondary analysis solution. The latest version includes out-of-the-box oncology ...

Preconfigured applications: DRAGEN v4.4 will offer "push-button" analysis for oncology workflows, including the first and ...

While Illumina and nanopore sequencing technologies differ fundamentally in their methodologies, they share several similarities. Both can sequence DNA and RNA, providing versatile platforms for ...

New generation sequencers, like Illumina's MiSeq devices, help determine the sequence of DNA or RNA to study genetic variation associated with diseases and diagnose rare genetic conditions.

Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...

The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

"We made a patterned flow cell using a more cost-efficient manufacturing process to help drive sequencing costs down. We've had these big step changes in the industry driven by Illumina.